Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 6
2004 2
2005 8
2006 6
2007 10
2008 10
2009 13
2010 17
2011 13
2012 19
2013 25
2014 31
2015 30
2016 28
2017 32
2018 41
2019 35
2020 34
2021 38
2022 32
2023 38
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

416 results

Results by year

Filters applied: . Clear all
Page 1
How we treat NK/T-cell lymphomas.
Tse E, Zhao WL, Xiong J, Kwong YL. Tse E, et al. J Hematol Oncol. 2022 Jun 3;15(1):74. doi: 10.1186/s13045-022-01293-5. J Hematol Oncol. 2022. PMID: 35659326 Free PMC article. Review.
Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a predilection for Asian and South American populations. Epstein-Barr virus (EBV) infection in lymphoma cells is universal. Predominantly extranodal, NK/T-cell lymph …
Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a predilection for Asian and South American populations. Epstei …
NK-/T-cell lymphomas.
Wang H, Fu BB, Gale RP, Liang Y. Wang H, et al. Leukemia. 2021 Sep;35(9):2460-2468. doi: 10.1038/s41375-021-01313-2. Epub 2021 Jun 11. Leukemia. 2021. PMID: 34117356 Free PMC article. Review.
Natural killer/T-cell lymphoma (NKTL) is a sub-type of Epstein-Barr virus (EBV)-related non-Hodgkin lymphomas common in Asia and Latin America but rare elsewhere. Its pathogenesis is complex and incompletely understood. Lymphoma ce …
Natural killer/T-cell lymphoma (NKTL) is a sub-type of Epstein-Barr virus (EBV)-related non-Hodgkin ly …
Review on natural killer/T-cell lymphoma.
He X, Gao Y, Li Z, Huang H. He X, et al. Hematol Oncol. 2023 Apr;41(2):221-229. doi: 10.1002/hon.2944. Epub 2021 Dec 9. Hematol Oncol. 2023. PMID: 34731509 Review.
Extranodal natural killer (NK)/T-cell lymphoma (ENKTL) is strongly associated with Epstein-Barr virus (EBV) and has a high prevalence in Asian and in Central and South America. ...Although clinical remission after L-asparaginase-based combination therapy has been achieved …
Extranodal natural killer (NK)/T-cell lymphoma (ENKTL) is strongly associated with Epstein-Barr virus (EBV) and has a high prevalence …
Extranodal T- and NK-cell lymphomas.
de Leval L, Feldman AL, Pileri S, Nakamura S, Gaulard P. de Leval L, et al. Virchows Arch. 2023 Jan;482(1):245-264. doi: 10.1007/s00428-022-03434-0. Epub 2022 Nov 7. Virchows Arch. 2023. PMID: 36336765 Free PMC article. Review.
Non-cutaneous extranodal NK/T cell lymphoproliferations constitute a heterogenous group of rare neoplasms, occurring primarily in the gastro-intestinal tract, nasal area, spleen, and liver. Their nomenclature refers to their usual clinical presentation …
Non-cutaneous extranodal NK/T cell lymphoproliferations constitute a heterogenous group of rare neoplasms, occur …
Extranodal NK/T cell lymphoma, nasal type: An updated overview.
Sánchez-Romero C, Bologna-Molina R, Paes de Almeida O, Santos-Silva AR, Prado-Ribeiro AC, Brandão TB, Carlos R. Sánchez-Romero C, et al. Crit Rev Oncol Hematol. 2021 Mar;159:103237. doi: 10.1016/j.critrevonc.2021.103237. Epub 2021 Jan 22. Crit Rev Oncol Hematol. 2021. PMID: 33493634 Review.
Extranodal NK/T-cell lymphoma, nasal type (ENKTCL-NT) is an aggressive malignancy associated with Epstein-Barr virus infection, with a geographic and racial predilection for some Asian and Latin American countries. ...For these reasons, we prese …
Extranodal NK/T-cell lymphoma, nasal type (ENKTCL-NT) is an aggressive malignancy associated with Epstein …
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma.
Li W, Duan X, Chen X, Zhan M, Peng H, Meng Y, Li X, Li XY, Pang G, Dou X. Li W, et al. Front Immunol. 2023 Jan 11;13:1079515. doi: 10.3389/fimmu.2022.1079515. eCollection 2022. Front Immunol. 2023. PMID: 36713430 Free PMC article. Review.
NPC has an insidious onset and is highly malignant, with more than 70% of patients having intermediate to advanced disease at the time of initial diagnosis, and is strongly implicated in epithelial cancers as well as malignant lymphoid and natural killer/T …
NPC has an insidious onset and is highly malignant, with more than 70% of patients having intermediate to advanced disease at the time of in …
Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS, Oon ML, Wang S, Tan SY, Ng SB. Hue SS, et al. Pathology. 2020 Jan;52(1):111-127. doi: 10.1016/j.pathol.2019.09.011. Epub 2019 Nov 22. Pathology. 2020. PMID: 31767131 Review.
They encompass a spectrum of entities that range from non-neoplastic lesions such as EBV-associated haemophagocytic lymphohistiocytosis (EBV-HLH) to more chronic conditions with variable outcomes such as chronic active EBV infections (CAEBV) of T- and NK-cell type (cutaneous and …
They encompass a spectrum of entities that range from non-neoplastic lesions such as EBV-associated haemophagocytic lymphohistiocytosis (EBV …
Estimating the global burden of Epstein-Barr virus-related cancers.
Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Wong Y, et al. J Cancer Res Clin Oncol. 2022 Jan;148(1):31-46. doi: 10.1007/s00432-021-03824-y. Epub 2021 Oct 27. J Cancer Res Clin Oncol. 2022. PMID: 34705104 Free PMC article. Review.
METHOD: We have reviewed the literature on defining features, distribution and outcomes across six cancers with a relatively large EBV-related case burden: Nasopharyngeal carcinoma (NPC), Gastric carcinoma (GC), Hodgkin lymphoma (HL), Burkitt lymphoma (BL), Diffuse …
METHOD: We have reviewed the literature on defining features, distribution and outcomes across six cancers with a relatively large EBV-relat …
NK/T-cell lymphomas.
Tse E, Kwong YL. Tse E, et al. Best Pract Res Clin Haematol. 2019 Sep;32(3):253-261. doi: 10.1016/j.beha.2019.06.005. Epub 2019 Jun 12. Best Pract Res Clin Haematol. 2019. PMID: 31585625 Review.
Non-nasal NK/T-cell lymphomas involve the skin, gastrointestinal tract, testis and other sites. Disseminated NK/T-cell lymphoma involves multiple organs, and may present with a leukemic phase. ...
Non-nasal NK/T-cell lymphomas involve the skin, gastrointestinal tract, testis and other sites. Disseminated NK/T-cell lymphoma …
EBV associated T- and NK-cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights.
Shafiee A, Shamsi S, Kohandel Gargari O, Beiky M, Allahkarami MM, Miyanaji AB, Aghajanian S, Mozhgani SH. Shafiee A, et al. Rev Med Virol. 2022 Jul;32(4):e2328. doi: 10.1002/rmv.2328. Epub 2022 Feb 4. Rev Med Virol. 2022. PMID: 35122349 Review.
The revised WHO classification classifies the lymphoproliferative diseases as: extranodal NK/T-cell lymphoma nasal type (ENKTL), aggressive NK-cell leukemia (ANKL), primary EBV-positive nodal T or NK cell lymphoma (NNKTL), systemic EBV-po …
The revised WHO classification classifies the lymphoproliferative diseases as: extranodal NK/T-cell lymphoma …
416 results